Indonesia Lifts FDI Restriction From 75% to 85% In Pharma Industry
This article was originally published in PharmAsia News
Executive Summary
Indonesia lifted its limit on foreign direct investments in the pharmaceutical industry companies from 75% to 85% as part of a revised "negative investment list" that bars or restricts investments in several sectors.